Thyroid Cancer Trial, Recruiting NCT04916990 Sponsor: University of Colorado, Denver Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT04916990
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who speak English or Spanish
  • People who are willing to follow all study procedures and take part for the full duration of the study
  • People who are receiving cancer treatment at one of these specific hospitals or cancer centers: UCHealth Aurora, UCHealth Highlands Ranch, UCHealth North, UCHealth Memorial Hospital, UCHealth Parkview Hospital, San Juan Cancer Center, RMCC-Pueblo, SCL-St. Mary's, or Parkview Medical Center
  • People who live in a rural county (as defined by Rural-Urban Continuum Codes 4–9) served by one of the participating hospitals or cancer centers listed in the trial
  • People who have been diagnosed with lung cancer (including small cell or non-small cell lung cancer, or other lung cancer types)
  • People who have been diagnosed with head and neck cancer (including cancers of the mouth, throat, voice box, or salivary glands, or other head and neck cancer types)
  • People who have been diagnosed with thyroid cancer
  • People who have been diagnosed with breast cancer
  • People who have been diagnosed with cervical cancer
  • People who have been diagnosed with colon or rectal cancer
  • People who have been diagnosed with bladder cancer
  • People who will be receiving surgery, radiation therapy, chemotherapy, or a combination of these treatments for their cancer, including treatment given before or after the main treatment
  • People who live in a rural area AND also live in an area officially recognised as having a shortage of health professionals or being medically underserved, AND/OR who have no health insurance (public or private), AND/OR who have public insurance (such as Medicaid, Medicare Part B only, or VA coverage) or spend 10% or more of their annual income on out-of-pocket medical costs

Who may not be able to join:

  • People under 18 years old
  • People who do not speak English or Spanish
  • People who are not receiving cancer treatment at one of the participating hospitals or cancer centers listed in the trial
  • People who have been diagnosed with a type of cancer not listed in the inclusion criteria above
  • People whose cancer type is listed in the inclusion criteria but whose treatment will not take place at one of the participating hospital sites
  • People who have already started curative treatment for their current cancer diagnosis before joining the trial
  • People in certain vulnerable situations at the time of joining, including those who are currently incarcerated or on probation, homeless, or pregnant (confirm with trial site)
  • People who have a cognitive or personality condition, are experiencing suicidal thoughts, or are under the influence of alcohol or drugs at the time of consent, in a way that would affect their ability to take part in the study
  • People who are unable to hear without an auditory aid (note: people who can hear with a hearing aid are not excluded)
  • People who are unlikely to be able to be contacted over time, such as those with no permanent address at the time of joining

Note: People who become homeless, pregnant, lose their hearing, or lose their permanent address after they have already joined the trial may be allowed to continue participating until the study is complete (confirm with trial site).


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Evelinn Borrayo, PhD, University of Colorado, Denver

Phone: 3037246278

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time to care

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov